Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Monday, March 29, 2010
Novartis / Antisoma : ASA404 - clinical trials, ain't they a bitch!
Antisoma's ASA404 doesn't show a survival benefit in a Phase III lung cancer study. The drug was one of company's two key late-stage products. ASA404 was being developed with Novartis.
No comments:
Post a Comment